Liquidia

Liquidia is a North Carolina-based biopharmaceutical company that researches and develops novel therapies for the treatment of pulmonary arterial hypertension.

Business Model:

Revenue: $13.8M

Employees: 11-50

Detailed Liquidia Information

Geographic Data

Liquidia headquarters map

Address: 419 Davis Drive

City: Morrisville

State: NC

Zip: 27560

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$50M

Raised Total:

$224M

Metrics

3,312,030Website Global Rank

4,884Website Monthly Traffic

Twitter Followers

Description

Liquidia is a North Carolina-based biopharmaceutical company that researches and develops novel therapies for the treatment of pulmonary arterial hypertension.

Contact Phone:
+19193284400

Contact Email:

Liquidia went public on 7/25/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/25/2018

IPO Valuation:
$166M

Ticker Symbol:
LQDA

IPO Price:
$11/share

Amount Raised:
$50M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2007 Series B 3 $16M Wakefield Group
New Enterprise Associates
Firelake Capital Management
Wakefield Group
New Enterprise Associates
Firelake Capital Management
3/2011 Venture Round 2 $10M Jenny Rooke
Bill &a; Melinda Gates Foundation
12/2019 Post-IPO Equity $0 Eshelman Ventures
Samsara BioCapital
AMDG 1
BKB Growth Investments
Canaan Partners
Sovereign’s Capital
Eshelman Ventures
Samsara BioCapital
AMDG 1
BKB Growth Investments
Canaan Partners
Sovereign’s Capital
6/2006 Series A 7 $6M W. Lowry Caudill
William Starling
Wakefield Group
Siemens AG
Next47
Firelake Capital Management
Alfred Childers
W. Lowry Caudill
William Starling
Wakefield Group
Siemens AG
Next47
Firelake Capital Management
Alfred Childers
1/2010 Series C 5 $20M Canaan Partners
Pappas Ventures
New Enterprise Associates
Morningside Group
Firelake Capital Management
Canaan Partners
12/2009 Grant 1 $3M NIST
NIST
1/2023 Post-IPO Debt 1 $32.5M HealthCare Royalty Partners
HealthCare Royalty Partners
1/2022 Post-IPO Debt 1 $20M Silicon Valley Bank
Silicon Valley Bank
4/2021 Post-IPO Equity 3 $21.7M Caligan Partners
Paul Manning
Roger Jeffs
Caligan Partners
Paul Manning
Roger Jeffs
7/2012 Private Equity Round $13.8M
4/2022 Post-IPO Equity $50M
1/2022 Post-IPO Debt $40M Silicon Valley Bank
12/2019 Post-IPO Equity $22.4M
4/2022 Post-IPO Equity $57.5M
3/2021 Post-IPO Debt $20.5M Silicon Valley Bank
1/2023 Post-IPO Debt $100M HealthCare Royalty
2/2018 Series D 4 $25.5M Xeraya Capital
New Enterprise Associates
Morningside Group
Canaan Partners
7/2010 Series C 5 $5M Pappas Ventures
New Enterprise Associates
Morningside Group
Firelake Capital Management
Canaan Partners
3/2021 Post-IPO Debt 1 $10.5M Silicon Valley Bank
Silicon Valley Bank
12/2019 Post-IPO Equity 6 $22.4M Eshelman Ventures
Samsara BioCapital
AMDG 1
BKB Growth Investments
Canaan Partners
Eshelman Ventures
Samsara BioCapital
AMDG 1
BKB Growth Investments
Canaan Partners
Announced Date Name Price
6/2020 RareGen

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research